Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-10

Clinical Trial Update: Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress [Phase 1, Phase 2]

View source ↗

Summary

This update notes a completed Phase 1/2 clinical trial evaluating vagal nerve stimulation for post-traumatic stress disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vagus nerve stimulation (VNS) device (Vagus nerve stimulation)

Snippet

Sponsor: VA Office of Research and Development | Conditions: Post-traumatic Stress | Phase 1, Phase 2 | Status: COMPLETED